logo-loader
LSE:CIR

Circassia Pharmaceuticals PLC

Market:
LSE
Market Cap:
£66.56 m
Price
17.74 GBX
Change
4.41%
52 weeks high
32.50
52 weeks low
12.50

In brief

Circassia is a specialty pharmaceutical company focused on respiratory disease. Our growing commercial organization promotes our innovative asthma management products directly to specialist physicians in a number of key markets, and we market the chronic obstructive pulmonary disease (COPD) product Tudorza® in the United States. We are expanding our commercial platform in China, and are working to expand our portfolio through in-licensing, partnering or acquisition. 

https://www.circassia.com/company/